Literature DB >> 9276518

Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans.

C Monari1, C Retini, B Palazzetti, F Bistoni, A Vecchiarelli.   

Abstract

The most important event involved in host defence against Cryptococcus neoformans is the development of an adequate cell-mediated immune response. IL-10, abundantly produced during AIDS progression, could be a negative factor that affects the T cell response through its own immunosuppressive action on antigen-presenting cells. To determine whether this cytokine affects the course of immune response against C. neoformans, we added exogenous IL-10 to cultured Cryptococcus-laden monocytes plus T lymphocytes. The data from this study confirmed the down-regulatory effect of exogenous IL-10 on monocytes and expanded the known inhibitory role to include an increase of the deleterious effect due to capsular material of C. neoformans on (i) lymphoproliferation, (ii) down-regulation of MHC class II molecules, (iii) inhibition of IL-2 mRNA expression and protein secretion by T lymphocytes. These results indicate that the presence of IL-10 in AIDS patients, due to the progression of disease, could represent a pivotal problem contributing to augment the pathogenic effect of C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276518      PMCID: PMC1904742          DOI: 10.1046/j.1365-2249.1997.4021303.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

Authors:  K V Clemons; G Grunig; R A Sobel; L F Mirels; D M Rennick; D A Stevens
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.

Authors:  Oscar Zaragoza; Mauricio Alvarez; Andrew Telzak; Johanna Rivera; Arturo Casadevall
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.

Authors:  C Retini; A Vecchiarelli; C Monari; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans.

Authors:  C Monari; T R Kozel; A Casadevall; D Pietrella; B Palazzetti; A Vecchiarelli
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

7.  Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection.

Authors:  Benjamin J Murdock; Seagal Teitz-Tennenbaum; Gwo-Hsiao Chen; Anthony J Dils; Antoni N Malachowski; Jeffrey L Curtis; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

8.  Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.

Authors:  Claudia M L Maffei; Laurence F Mirels; Raymond A Sobel; Karl V Clemons; David A Stevens
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody.

Authors:  R M Syme; T F Bruno; T R Kozel; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

10.  Role and relevance of mast cells in fungal infections.

Authors:  R Saluja; M Metz; Marcus Maurer
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.